The so-called multidrug resistance （MDR） of leukemic cells means the cross resistance of leukemic cells against multiple anti-tumor agents with different constitution and acting mechanism, which takes place simultan...The so-called multidrug resistance （MDR） of leukemic cells means the cross resistance of leukemic cells against multiple anti-tumor agents with different constitution and acting mechanism, which takes place simultaneous after resistance to a single contacted drug has been produced. Tumor cells with MDR would now show a low sensitivity to anti-tumor agents, making chemotherapy ineffective or of little effect. Moreover, MDR is one of the pathogenetic factors for inducing refractory leukemia.展开更多
OBJECTIVE: To address the optimal Chinese herbal injections(CHIs) against liver cancer, the present network Meta-analysis is designed to investigate the comparative efficacy and safety of different CHIs.METHODS: Sever...OBJECTIVE: To address the optimal Chinese herbal injections(CHIs) against liver cancer, the present network Meta-analysis is designed to investigate the comparative efficacy and safety of different CHIs.METHODS: Several electronic databases were searched up to June 1 st, 2017. The quality assessment was conducted and network Meta-analysis was performed to compare the efficacy and safety of different CHIs plus transcatheter hepatic arterial chemoembolization(TACE). Primary outcomes were 1-year and 2-year survival rate, the secondary outcomes includes the clinical effective rate, performance status and the adverse reactions(ADRs). Data analysis was applied Stata 13.0 and Win BUGS 1.4 software.RESULTS: A total of 105 randomized controlled trials(RCTs) were identified for inclusion in this analysis, with data for 7683 patients and 13 CHIs. The results suggested that Javanica oil emulsion,Huachansu injection plus TACE were more favorable for 1-year and 2-year survival rate than other CHIs. Kanglaite, Astragalus polysaccharide injection plus TACE showed superiority in the clinical effective rate and performance status over other CHIs.And Shenmai injection plus TACE was superior to reducing ADRs than other CHIs for patients with liver cancer.CONCLUSION: Our findings indicated that receiving CHIs combined with TACE may have therapeutic benefits for patients with liver cancer in improving survival rate, clinical effective rate, the performance status and alleviating the ADRs.展开更多
Cross-kingdom herbal mi RNA was first reported in 2012.Using a modified herbal extraction protocol,we obtained 73,677,287sequences by RNA-seq from 245 traditional Chinese Medicine(TCM),of which 20,758,257 were unique ...Cross-kingdom herbal mi RNA was first reported in 2012.Using a modified herbal extraction protocol,we obtained 73,677,287sequences by RNA-seq from 245 traditional Chinese Medicine(TCM),of which 20,758,257 were unique sequences.We constructed a Bencao(herbal)small RNA(s RNA)Atlas(http://bencao.bmicc.cn),annotated the sequences by sequence-based clustering,and created a nomenclature system for Bencao s RNAs.The profiles of 21,757 mi RNAs in the Atlas were highly consistent with those of plant mi RNAs in mi RBase.Using software tools,our results demonstrated that all human genes might be regulated by s RNAs from the Bencao s RNA Atlas,part of the predicted human target genes were experimentally validated,suggesting that Bencao s RNAs might be one of the main bioactive components of herbal medicines.We established roadmaps for oligonucleotide drugs development and optimization of TCM prescriptions.Moreover,the decoctosome,a lipo-nano particle consisting of 0.5%–2.5%of the decoction,demonstrated potent medical effects.We propose a Bencao(herbal)Index,including small-molecule compounds(SM),protein peptides(P),nucleic acid(N),non-nucleic and non-proteinogenic large-molecule compounds(LM)and elements from Mendeleev's periodic table(E),to quantitatively measure the medical effects of botanic medicine.The Bencao s RNA Atlas is a resource for developing gene-targeting oligonucleotide drugs and optimizing botanical medicine,and may provide potential remedies for the theory and practice of one medicine.展开更多
目的:探讨丝裂原活化蛋白激酶(MAPK)p38在健脾清化方改善模型大鼠慢性肾衰竭肾纤维化中的作用。方法:SPF级SD大鼠分为假手术组(n=10)、模型组(n=10)、健脾清化方组(n=10)、氯沙坦组(n=10)。健脾清化方组每日灌胃1次,每次3.9 g/200 g大鼠...目的:探讨丝裂原活化蛋白激酶(MAPK)p38在健脾清化方改善模型大鼠慢性肾衰竭肾纤维化中的作用。方法:SPF级SD大鼠分为假手术组(n=10)、模型组(n=10)、健脾清化方组(n=10)、氯沙坦组(n=10)。健脾清化方组每日灌胃1次,每次3.9 g/200 g大鼠,连续60 d;氯沙坦组每日灌胃1次,每次3.3 g/200 g大鼠,连续60 d;假手术组和模型组等体积生理盐水灌胃。5/6肾切除大鼠模型(Platt法),采用生化法检测大鼠血清肌酐、尿素氮,蛋白质印迹法检测MAPK p38,HE染色观察肾脏组织病理学变化。结果:与模型组比较,健脾清化方、氯沙坦能显著降低血清肌酐水平(42.67±5.98 vs 60.90±9.54,40.90±5.07 vs 60.90±9.54,均P<0.01)及MAPK p38表达(0.555±0.004 vs 0.930±0.265,0.587±0.045 vs 0.930±0.265,均P<0.01),降低大鼠血清尿素氮水平(8.56±0.75 vs 8.62±0.62,7.97±0.86 vs 8.62±0.62,均P<0.05);模型组可见肾小球增生,系膜细胞轻度增生,间质炎性细胞浸润,健脾清化方组、氯沙坦组与模型组比较病变明显减轻,且健脾清化方组较氯沙坦组病变减轻更明显。结论:健脾清化方对Platt模型大鼠的肾功能和肾脏病理有一定的改善作用,该机制可能与健脾清化方对MAPK p38相关免疫炎症通路的抑制有关。展开更多
文摘The so-called multidrug resistance （MDR） of leukemic cells means the cross resistance of leukemic cells against multiple anti-tumor agents with different constitution and acting mechanism, which takes place simultaneous after resistance to a single contacted drug has been produced. Tumor cells with MDR would now show a low sensitivity to anti-tumor agents, making chemotherapy ineffective or of little effect. Moreover, MDR is one of the pathogenetic factors for inducing refractory leukemia.
基金Supported by the National Natural Science Foundation of China(Study on the Key Influential Factors of Anaphylaxis Induced by Chinese Herbal Injection Based on Three-dimensional Database and Multi-dimensional Data Mining,No.81473547Establishment of Multi-dimensional Clinical Evaluation Model of Danshen Injection for Treating Unstable Angina Pectoris Based on Bayesian Network Meta Analysis,No.81673829)。
文摘OBJECTIVE: To address the optimal Chinese herbal injections(CHIs) against liver cancer, the present network Meta-analysis is designed to investigate the comparative efficacy and safety of different CHIs.METHODS: Several electronic databases were searched up to June 1 st, 2017. The quality assessment was conducted and network Meta-analysis was performed to compare the efficacy and safety of different CHIs plus transcatheter hepatic arterial chemoembolization(TACE). Primary outcomes were 1-year and 2-year survival rate, the secondary outcomes includes the clinical effective rate, performance status and the adverse reactions(ADRs). Data analysis was applied Stata 13.0 and Win BUGS 1.4 software.RESULTS: A total of 105 randomized controlled trials(RCTs) were identified for inclusion in this analysis, with data for 7683 patients and 13 CHIs. The results suggested that Javanica oil emulsion,Huachansu injection plus TACE were more favorable for 1-year and 2-year survival rate than other CHIs. Kanglaite, Astragalus polysaccharide injection plus TACE showed superiority in the clinical effective rate and performance status over other CHIs.And Shenmai injection plus TACE was superior to reducing ADRs than other CHIs for patients with liver cancer.CONCLUSION: Our findings indicated that receiving CHIs combined with TACE may have therapeutic benefits for patients with liver cancer in improving survival rate, clinical effective rate, the performance status and alleviating the ADRs.
基金the National Natural Science Foundation of China(81788101,32100104)the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2021-I2M-1022)+1 种基金the CAMS Endowment Fund(2021-CAMS-JZ001)the Overseas Expertise Introduction Center for Discipline Innovation(“111 Center”)(BP0820029)。
文摘Cross-kingdom herbal mi RNA was first reported in 2012.Using a modified herbal extraction protocol,we obtained 73,677,287sequences by RNA-seq from 245 traditional Chinese Medicine(TCM),of which 20,758,257 were unique sequences.We constructed a Bencao(herbal)small RNA(s RNA)Atlas(http://bencao.bmicc.cn),annotated the sequences by sequence-based clustering,and created a nomenclature system for Bencao s RNAs.The profiles of 21,757 mi RNAs in the Atlas were highly consistent with those of plant mi RNAs in mi RBase.Using software tools,our results demonstrated that all human genes might be regulated by s RNAs from the Bencao s RNA Atlas,part of the predicted human target genes were experimentally validated,suggesting that Bencao s RNAs might be one of the main bioactive components of herbal medicines.We established roadmaps for oligonucleotide drugs development and optimization of TCM prescriptions.Moreover,the decoctosome,a lipo-nano particle consisting of 0.5%–2.5%of the decoction,demonstrated potent medical effects.We propose a Bencao(herbal)Index,including small-molecule compounds(SM),protein peptides(P),nucleic acid(N),non-nucleic and non-proteinogenic large-molecule compounds(LM)and elements from Mendeleev's periodic table(E),to quantitatively measure the medical effects of botanic medicine.The Bencao s RNA Atlas is a resource for developing gene-targeting oligonucleotide drugs and optimizing botanical medicine,and may provide potential remedies for the theory and practice of one medicine.
文摘目的:探讨丝裂原活化蛋白激酶(MAPK)p38在健脾清化方改善模型大鼠慢性肾衰竭肾纤维化中的作用。方法:SPF级SD大鼠分为假手术组(n=10)、模型组(n=10)、健脾清化方组(n=10)、氯沙坦组(n=10)。健脾清化方组每日灌胃1次,每次3.9 g/200 g大鼠,连续60 d;氯沙坦组每日灌胃1次,每次3.3 g/200 g大鼠,连续60 d;假手术组和模型组等体积生理盐水灌胃。5/6肾切除大鼠模型(Platt法),采用生化法检测大鼠血清肌酐、尿素氮,蛋白质印迹法检测MAPK p38,HE染色观察肾脏组织病理学变化。结果:与模型组比较,健脾清化方、氯沙坦能显著降低血清肌酐水平(42.67±5.98 vs 60.90±9.54,40.90±5.07 vs 60.90±9.54,均P<0.01)及MAPK p38表达(0.555±0.004 vs 0.930±0.265,0.587±0.045 vs 0.930±0.265,均P<0.01),降低大鼠血清尿素氮水平(8.56±0.75 vs 8.62±0.62,7.97±0.86 vs 8.62±0.62,均P<0.05);模型组可见肾小球增生,系膜细胞轻度增生,间质炎性细胞浸润,健脾清化方组、氯沙坦组与模型组比较病变明显减轻,且健脾清化方组较氯沙坦组病变减轻更明显。结论:健脾清化方对Platt模型大鼠的肾功能和肾脏病理有一定的改善作用,该机制可能与健脾清化方对MAPK p38相关免疫炎症通路的抑制有关。
